Changes in Beneficial Ownership · 4
Harmony Biosciences Holdings, Inc.
HRMYNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4-05182026_080544.xml
Filing details
- Report period
- 2026-05-14
- Issuer
- Harmony Biosciences Holdings, Inc.
- Issuer CIK
- 0001802665
- Trading symbol
- HRMY
Reporting owner 1
- Name
- Szyper Linda M
- Reporting owner CIK
- 0001739050
- Relationship
- Director
- Address
- C/O HARMONY BIOSCIENCES HOLDINGS, INC., 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | 30.76 | 2026-05-14 | A · Form 4 | 21,872 | A | 0 | [F1] | 2036-05-14 | Common Stock | 21,872 | 21,872 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.↩ 1
Signature 1
- Signed
- /s/ Christian Ulrich, Attorney-in-Fact
- Date
- 2026-05-18
Company context
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, Pa., we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit www.harmonybiosciences.com.
Current securities
Recent company filings
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureOct 13, 2026
- 144 filingAug 7, 2026
- 10-Q filingAug 4, 2026
- Results of Operations and Financial Condition · Regulation FD DisclosureAug 4, 2026
- SCHEDULE 13G - filed by VANGUARD PORTFOLIO MANAGEMENT LLC regarding Harmony Biosciences Holdings, Inc.Jul 31, 2026